Search results for:

cyclophosphamide PO

cyclophosphamide PO
Brand names: Cytoxan
Form Strength
TABLET, ORAL 50 mg

High Alert Drug : Policy

Medication comments:

High Alert Drug: Chemotherapeutic Agents - Oral
 • Stored separately in pharmacy.
 • Drugs are transported in plastic bags/designated transport containers labeled with sticker indicating CHEMOTHERAPY DRUG.
Per policy, these hazardous drugs have special waste requirements. 
Generic (Brand) Waste Requirements
cyclophosphamide (Cytoxan) If > 3% by weight of drug remains ⇒  BLACK BUCKET 
Trace amounts/uncontaminated PPE ⇒  YELLOW BUCKET 
USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]
Activities
cyclophosphamide (Cytoxan) PO
[BULK ⇒ Blister UD]
 50 mg capsule Stock @ IDBH? N
NIOSH Table 1A
Pharmacy:
Receiving / Storage / Preparation


Exposure Risk: low
• Handling/preparation PPE Requirements: Double CX glove and gown
• Receiving from Distributor: Designated area/ CX gloves
• Pharmacy Storage Area: Hazardous
• Packaging/Reconstitution Location: Repackage area
• Compounding (Non-Sterile/Sterile) Location: n/a
• Omnicell Load: No
Transport • Transport (dose is placed inside a plastic sealable bag): Standard
Nursing:
Storage / Administration


Exposure Risk: low
• Handling/administration PPE Requirements: Single pair of CX approved gloves. Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer
• Signage on Patient Door Required: Yes
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: Swallow whole; do not crush or chew; do not open capsules.
Disposal / Spills • Disposal of Drug Waste: Full -  black bin , Trace -  yellow bin 
• Disposol of Used PPE:  yellow bin 
• Spill management: n/a
NIOSH Supplemental Information: IARC Group 1 carcinogen; NTP

Last updated: Jun. 18, 2025
  • Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
  • Hazardous Waste BLACK BUCKET/YELLOW BUCKET
  • Chemotherapy



Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.